Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06332781
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-28
First Post:
2023-12-13
Brief Title:
Intravesical Gentamicin to Prevent Recurrent UTI
Sponsor:
Women and Infants Hospital of Rhode Island
Organization:
Women and Infants Hospital of Rhode Island
Study Overview
Official Title:
Intravesical Gentamicin to Prevent Recurrent UTI
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Feasibility assessment of intravesical gentamicin instillation putting antibiotics directly into the bladder versus the current standard of care of oral nitrofurantoin prophylaxis taking a low dose of antibiotics by mouth every day to prevent recurrent urinary tract infections UTI
Detailed Description:
The overall goal of this project is to assess the feasibility of a larger trial investigating the use of intravesical gentamicin instillation putting antibiotics directly into the bladder versus the current standard of care of oral nitrofurantoin prophylaxis taking a low dose of antibiotics by mouth every day Investigators plan to gain patient perspective regarding preferences for study design and assess associations between the treatments with changes in the postmenopausal urinary microbiome urobiome
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None